Project Grant 2151532
Award Date
3/1/22
Completion Date
8/31/22
Dollars Obligated
$256K
Federal Agency
Division of Industrial Innovation
Federal Grant Program
47.041
Assistance Type
Project Grant
Place of Performance
Syracuse, NY 13202, USA
Similar Awards
This $300,000 Project Grant awarded by the National Science Foundation (NSF) under the Integrative Activities (CFDA 47.083) program supports the development of an innovative, intelligent surgical probe for prostate cancer treatment. The project aims to create an edge artificial intelligence (AI) system-on-chip for bioimpedance analysis that can accurately distinguish cancerous from healthy tissue during prostate removal surgery. The novel technology being developed includes an adaptive filter to...
This Project Grant award from the National Cancer Institute (NCI), under the Cancer Detection and Diagnosis Research program (CFDA 93.394), is focused on integrating radiologist insights to develop advanced AI-assisted systems for interpreting prostate MRI scans. The $245,087 award will fund a collaboration between Memorial Sloan Kettering (MSK) radiologists and researchers at the University of Delaware (UD) to achieve the following key objectives: Curate a comprehensive dataset by annotating...
This $255,807 National Science Foundation project grant will fund the development of an AI-assisted software system to accelerate the labeling of medical tomographic images. Administered through the NSF Directorate for Engineering's Engineering program (CFDA 47.041), the grant aims to extract new information from medical images and improve patient outcomes. Alienbyte Scientific Software Inc. will apply machine learning algorithms to create an adaptive system that evolves to increase the speed,...
The National Science Foundation awarded $256,000 to Optave Diagnostics LLC through the Technology, Innovation, and Partnerships program (CFDA 47.084) to develop a prototype endoscopic probe for molecular imaging and diagnosis of cancerous prostate pathologies. The 12-month project grant will support the creation of a medical device using photoacoustic imaging and acoustic lens technology to aid in the detection and diagnosis of prostate cancer. The proposed endoscopic probe offers an alternative...
This National Science Foundation (NSF) Technology, Innovation, and Partnerships (CFDA 47.084) Project Grant awarded to Bioimaginix LLC, a for-profit small business, aims to develop a low-cost diagnostic tool for Alzheimer's disease (AD) and mild cognitive impairment (MCI) using artificial intelligence (AI) and machine learning (ML) algorithms applied to magnetic resonance imaging (MRI) brain scans. The $303,089 award will fund the creation of an AI-based platform that can distinguish AD from MCI...
This Project Grant award from the National Science Foundation (CFDA 47.084 - NSF Technology, Innovation, and Partnerships) provides $249,979 to the H. Lee Moffitt Cancer Center and Research Institute Hospital, Inc. to develop a Trustworthy Artificial Intelligence (AI) solution for identifying and marking the boundaries of brain tumors in magnetic resonance imaging (MRI) scans. The project, titled "PFI-TT: TRUSTWORTHY ARTIFICIAL INTELLIGENCE FOR THE VOLUMETRIC EVALUATION OF BRAIN...
This Project Grant award of $680,433 from the National Cancer Institute (NCI) under the Cancer Detection and Diagnosis Research program (CFDA 93.394) supports research at the University of California, San Francisco (UCSF) to improve prognostic estimation and understanding of prostate cancer heterogeneity and biology. The key goals are to: 1) understand the relationships between established genomic tests and pathology artificial intelligence (PAI) algorithms in predicting outcomes after...
This National Science Foundation (NSF) Project Grant, awarded under the Computer and Information Science and Engineering program (CFDA 47.070), provides $220,000 to Yale University from September 1, 2023 through August 31, 2027. The project aims to develop a smarter artificial intelligence (AI) system to better understand and analyze complex medical images, such as those from multiple scans of a patient. The research team will tackle challenges to make the AI system more scalable, interpretable,...
This federal Project Grant award of $568,151 from the National Cancer Institute (CFDA 93.394 - Cancer Detection and Diagnosis Research) supports the development of a real-time functional photoacoustic imaging platform to enable sensitive detection of prostate cancer tumors and accurate characterization of their aggressiveness. The key products and services to be delivered through this 5-year award include: Optimization of biocompatible polyacrylamide hydrogel nanoparticle (PAA NP) probes for...
This $365,887 federal Project Grant award from the National Science Foundation (NSF) under the Technology, Innovation, and Partnerships (CFDA 47.084) program aims to develop an innovative artificial intelligence (AI) technology to select optimal treatment options for individual cancer patients. The goal is to prolong patient life and reduce healthcare costs by avoiding initial treatment failures. The project will establish connections with innovation networks, accelerate market-oriented...